Bank of Nova Scotia’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-51,879
| Closed | -$2.47M | – | 952 |
|
|
2024
Q2 | $2.47M | Buy |
+51,879
| New | +$2.47M | ﹤0.01% | 597 |
|
|
2023
Q3 | – | Sell |
-78,042
| Closed | -$3.2M | – | 1003 |
|
|
2023
Q2 | $3.2M | Buy |
78,042
+36,636
| +88% | +$1.5M | 0.01% | 436 |
|
|
2023
Q1 | $1.48M | Buy |
41,406
+10,406
| +34% | +$372K | ﹤0.01% | 618 |
|
|
2022
Q4 | $1.17M | Buy |
+31,000
| New | +$1.17M | ﹤0.01% | 773 |
|
|
2022
Q1 | – | Sell |
-601,883
| Closed | -$18.3M | – | 1212 |
|
|
2021
Q4 | $18.3M | Buy |
601,883
+589,568
| +4,787% | +$17.9M | 0.03% | 381 |
|
|
2021
Q3 | $413K | Sell |
12,315
-1,220
| -9% | -$40.9K | ﹤0.01% | 1001 |
|
|
2021
Q2 | $540K | Buy |
+13,535
| New | +$540K | ﹤0.01% | 921 |
|
|
2018
Q2 | – | Sell |
-75,000
| Closed | -$3.31M | – | 877 |
|
|
2018
Q1 | $3.31M | Buy |
75,000
+41,201
| +122% | +$1.82M | 0.02% | 450 |
|
|
2017
Q4 | $1.7M | Sell |
33,799
-8,201
| -20% | -$412K | 0.01% | 635 |
|
|
2017
Q3 | $2.13M | Buy |
42,000
+12,000
| +40% | +$608K | 0.01% | 562 |
|
|
2017
Q2 | $1.53M | Buy |
+30,000
| New | +$1.53M | 0.01% | 676 |
|
|
2017
Q1 | – | Sell |
-300,000
| Closed | -$14.3M | – | 873 |
|
|
2016
Q4 | $14.3M | Buy |
+300,000
| New | +$14.3M | 0.07% | 159 |
|